Literature DB >> 31433067

In Focus: Disease promoters during epileptogenesis.

Thimmasettappa Thippeswamy1.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 31433067      PMCID： PMC6753052          DOI： 10.1002/jnr.24518

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN： 0360-4012            Impact factor:   4.164


× No keyword cloud information.
  13 in total

1.  mTOR Inhibitors as a New Therapeutic Strategy in Treatment Resistant Epilepsy in Hemimegalencephaly: A Case Report.

Authors:  Qi Xu; Shimrit Uliel-Sibony; Christopher Dunham; Harvey Sarnat; Laura Flores-Sarnat; Ledia Brunga; Scott Davidson; Winnie Lo; Adam Shlien; Mary Connolly; Cyrus Boelman; Anita Datta
Journal:  J Child Neurol       Date:  2018-12-05       Impact factor: 1.987

2.  Antiepileptogenesis and seizure prevention trials with antiepileptic drugs: meta-analysis of controlled trials.

Authors:  N R Temkin
Journal:  Epilepsia       Date:  2001-04       Impact factor: 5.864

Review 3.  Drug-resistant epilepsy.

Authors:  Patrick Kwan; Steven C Schachter; Martin J Brodie
Journal:  N Engl J Med       Date:  2011-09-08       Impact factor: 91.245

Review 4.  Astrocytes and Glutamine Synthetase in Epileptogenesis.

Authors:  Tore Eid; Tih-Shih W Lee; Peter Patrylo; Hitten P Zaveri
Journal:  J Neurosci Res       Date:  2018-07-18       Impact factor: 4.164

Review 5.  Glial source of nitric oxide in epileptogenesis: A target for disease modification in epilepsy.

Authors:  Shaunik Sharma; Sreekanth Puttachary; Thimmasettappa Thippeswamy
Journal:  J Neurosci Res       Date:  2017-12-12       Impact factor: 4.164

Review 6.  Progress report on new antiepileptic drugs: A summary of the Thirteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XIII).

Authors:  Meir Bialer; Svein I Johannessen; René H Levy; Emilio Perucca; Torbjörn Tomson; H Steve White
Journal:  Epilepsia       Date:  2017-01-23       Impact factor: 5.864

7.  Epilepsy after the first drug fails: substitution or add-on?

Authors:  P Kwan; M J Brodie
Journal:  Seizure       Date:  2000-10       Impact factor: 3.184

8.  Decision-making in patients with temporal lobe epilepsy: Delay gratification ability is not impaired in patients with hippocampal sclerosis.

Authors:  Patricia Rzezak; Ellen Marise Lima; Fabricio Pereira; Ana Carolina Gargaro; Erica Coimbra; Silvia de Vincentiis; Tonicarlo Rodrigues Velasco; João Pereira Leite; Geraldo F Busatto; Kette D Valente
Journal:  Epilepsy Behav       Date:  2016-05-18       Impact factor: 2.937

9.  1400W, a highly selective inducible nitric oxide synthase inhibitor is a potential disease modifier in the rat kainate model of temporal lobe epilepsy.

Authors:  Sreekanth Puttachary; Shaunik Sharma; Saurabh Verma; Yang Yang; Marson Putra; Achala Thippeswamy; Diou Luo; Thimmasettappa Thippeswamy
Journal:  Neurobiol Dis       Date:  2016-05-18       Impact factor: 5.996

Review 10.  Converging early responses to brain injury pave the road to epileptogenesis.

Authors:  Eric J Neuberger; Akshay Gupta; Deepak Subramanian; Akshata A Korgaonkar; Vijayalakshmi Santhakumar
Journal:  J Neurosci Res       Date:  2017-11-29       Impact factor: 4.164
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.